Article

FDA accepts new drug application for ED topical cream

FDA has accepted a new drug application for a topically applied alprostadil cream for the treatment of erectile dysfunction, according to NexMed, Inc., the drug’s developer.

FDA has accepted a new drug application for a topically applied alprostadil cream for the treatment of erectile dysfunction, according to NexMed, Inc., the drug’s developer.

The acceptance for review is an indication that FDA has determined that the filing is sufficient to complete a substantive review of the application, which customarily takes a minimum of 8 months, should the agency not require any additional studies or information, the company said.

Related Videos
Blurred interior of hospital | Image Credit: © jakkapan - stock.adobe.com
Related Content
© 2025 MJH Life Sciences

All rights reserved.